The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2SEVENTY BIO INC | COMMON STOCK | 901384107 | 2,037 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| ADICET BIO INC | COM | 007002108 | 2,133 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 7,007 | 2,883,710 | SH | SOLE | 2,883,710 | 0 | 0 | ||
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 846 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
| AFFIMED N V | COM | N01045108 | 1,854 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 4,767 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| AKOYA BIOSCIENCES INC | COM | 00974H104 | 3,478 | 296,000 | SH | SOLE | 296,000 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 1,563 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| ALPHATEC HLDGS INC | COM NEW | 02081G201 | 2,989 | 342,000 | SH | SOLE | 342,000 | 0 | 0 | ||
| AMYLYX PHARMACEUTICALS INC | PUT | 03237H951 | 253 | 9,000 | SH | Put | SOLE | 9,000 | 0 | 0 | |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 985 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| ANGIODYNAMICS INC | COM | 03475V101 | 3,990 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| ARCELLX INC | COMMON STOCK | 03940C100 | 2,159 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 991 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 4,023 | 445,000 | SH | SOLE | 445,000 | 0 | 0 | ||
| AULT DISRUPTIVE TECHS CORP | COM | 05150A104 | 1,512 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| AULT DISRUPTIVE TECHS CORP | *W EXP 99/99/999 | 05150A112 | 5 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 2,450 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,002 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 11,954 | 1,132,000 | SH | SOLE | 1,132,000 | 0 | 0 | ||
| BENITEC BIOPHARMA INC | COM | 08205P100 | 245 | 658,796 | SH | SOLE | 658,796 | 0 | 0 | ||
| BIOATLA INC | COM | 09077B104 | 4,258 | 553,000 | SH | SOLE | 553,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADS | 09071M205 | 3,838 | 4,149,262 | SH | SOLE | 4,149,262 | 0 | 0 | ||
| BRUUSH ORAL CARE INC | *W EXP 08/03/202 | 11750K120 | 52 | 120,193 | SH | SOLE | 120,193 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 1,806 | 193,000 | SH | SOLE | 193,000 | 0 | 0 | ||
| CASTLE BIOSCIENCES INC | COM | 14843C105 | 1,565 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 38 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 7 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 8,266 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 10,322 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
| CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 59 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
| CLENE INC | PUT | 185634952 | 788 | 281,500 | SH | Put | SOLE | 281,500 | 0 | 0 | |
| COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 2 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | ||
| COLISEUM ACQUISITION CORP | CLASS A ORD SHS | G2263T123 | 835 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 1,858 | 116,000 | SH | SOLE | 116,000 | 0 | 0 | ||
| COLOMBIER ACQUISITION CORP | *W EXP 99/99/999 | 19533H116 | 2 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | ||
| COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 488 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 2,485 | 427,000 | SH | SOLE | 427,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 6,125 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| DIGITAL HEALTH ACQUISITION C | UNIT 11/02/2026 | 253893200 | 1,545 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| DIRECT DIGITAL HOLDINGS INC | *W EXP 02/15/202 | 25461T113 | 49 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 562 | 60,876 | SH | SOLE | 60,876 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 3,313 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 4,421 | 659,869 | SH | SOLE | 659,869 | 0 | 0 | ||
| EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 4,008 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 5 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,776 | 224,541 | SH | SOLE | 224,541 | 0 | 0 | ||
| FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 1,171 | 227,000 | SH | SOLE | 227,000 | 0 | 0 | ||
| GIGINTERNATIONAL1 INC | *W EXP 04/19/202 | 37518W114 | 3 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| GLAUKOS CORP | COM | 377322102 | 5,164 | 97,000 | SH | SOLE | 97,000 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 1,617 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| GSR II METEORA ACQUISITN COR | UNIT 02/24/2027 | 36263W204 | 514 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| GUARDANT HEALTH INC | COM | 40131M109 | 3,553 | 66,000 | SH | SOLE | 66,000 | 0 | 0 | ||
| GUARDANT HEALTH INC | CALL | 40131M909 | 5,383 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| HARBOR CUSTOM DEVELOPMENT IN | *W EXP 10/04/202 | 41150T124 | 114 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 91 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 99 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| HILLMAN SOLUTIONS CORP | COM | 431636109 | 1,666 | 221,000 | SH | SOLE | 221,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 4,197 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
| INDUSTRIAL HUMAN CAPITAL INC | COM | 45617P104 | 1,015 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| INDUSTRIAL HUMAN CAPITAL INC | *W EXP 11/27/202 | 45617P112 | 2 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| INNOVATIVE EYEWEAR INC | *W EXP 08/16/202 | 45791D117 | 60 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| INOGEN INC | COM | 45780L104 | 3,545 | 146,000 | SH | SOLE | 146,000 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 5,773 | 268,000 | SH | SOLE | 268,000 | 0 | 0 | ||
| INSPIRE MED SYS INC | COM | 457730109 | 2,128 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
| INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 4,653 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 2,243 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| JEFFS BRANDS LTD | *W EXP 08/26/202 | M61472110 | 40 | 240,385 | SH | SOLE | 240,385 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,994 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 3,824 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 4,095 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 3,311 | 88,000 | SH | SOLE | 88,000 | 0 | 0 | ||
| KORU MEDICAL SYSTEMS INC | COM | 759910102 | 2,220 | 995,500 | SH | SOLE | 995,500 | 0 | 0 | ||
| LAKESHORE ACQUISITION I CORP | *W EXP 07/15/202 | G53521111 | 30 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| LAKESHORE ACQUISITION II COR | ORDINARY SHARES | G5352N105 | 2,016 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 2,954 | 42,000 | SH | SOLE | 42,000 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,024 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| LIGHTNING EMOTORS INC | *W EXP 05/18/202 | 53228T119 | 120 | 652,173 | SH | SOLE | 652,173 | 0 | 0 | ||
| MEDIWOUND LTD | ORD SHS | M68830104 | 1,775 | 1,276,948 | SH | SOLE | 1,276,948 | 0 | 0 | ||
| MURPHY CANYON ACQUISITION CO | UNIT 01/25/2027 | 626642201 | 1,004 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MUSCLE MAKER INC | COM | 627333107 | 666 | 1,771,331 | SH | SOLE | 1,771,331 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 3,549 | 186,000 | SH | SOLE | 186,000 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 3,576 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | 3,287 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,018 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | ||
| NEVRO CORP | COM | 64157F103 | 2,982 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | ||
| NEXALIN TECHNOLOGY INC | *W EXP 09/15/202 | 65345B110 | 19 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 68 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| NLS PHARMACEUTICS LTD | *W EXP 09/25/202 | H57830111 | 43 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| NOCTURNE ACQUISITION CORP | ORDINARY SHARES | G6580S114 | 5,165 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 22 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| NOVABAY PHARMACEUTICALS INC | COM NEW | 66987P201 | 121 | 1,095,957 | SH | SOLE | 1,095,957 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 2,146 | 517,133 | SH | SOLE | 517,133 | 0 | 0 | ||
| OMEGA ALPHA SPAC | CL A | G6749V107 | 993 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ONFOLIO HOLDINGS INC | *W EXP 01/02/202 | 68277K124 | 30 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| OPY ACQUISITION CORP I | COM CL A | 671005106 | 993 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| OPY ACQUISITION CORP I | *W EXP 09/22/202 | 671005114 | 5 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| PALISADE BIO INC | COM | 696389105 | 559 | 5,643,007 | SH | SOLE | 5,643,007 | 0 | 0 | ||
| PEPGEN INC | COM | 713317105 | 363 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| PEPPERLIME HEALTH ACQUSTN CO | *W EXP 10/01/202 | G70021111 | 27 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | ||
| PEPPERLIME HEALTH ACQUSTN CO | CLASS A ORD SHS | G70021103 | 7,343 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
| PLIANT THERAPEUTICS INC | COM | 729139105 | 4,491 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
| POLISHED COM INC | *W EXP 06/02/202 | 28252C117 | 763 | 6,103,824 | SH | SOLE | 6,103,824 | 0 | 0 | ||
| PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 3,358 | 81,000 | SH | SOLE | 81,000 | 0 | 0 | ||
| QUANTERIX CORP | COM | 74766Q101 | 1,047 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| QUIDELORTHO CORP | COM | 219798105 | 3,574 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| RELATIVITY ACQUISITION CORP | UNIT 02/10/2027 | 75944B205 | 1,008 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 315 | 8,500 | SH | SOLE | 8,500 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | PUT | 75955J952 | 674 | 18,200 | SH | Put | SOLE | 18,200 | 0 | 0 | |
| RENOVACOR INC | COM | 75989E106 | 980 | 388,845 | SH | SOLE | 388,845 | 0 | 0 | ||
| RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 58 | 731,561 | SH | SOLE | 731,561 | 0 | 0 | ||
| RESMED INC | COM | 761152107 | 3,711 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 4,165 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| SARISSA CAPITAL ACQUISITN CO | CL A | G7823W102 | 2,250 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| SARISSA CAPITAL ACQUISITN CO | *W EXP 10/23/202 | G7823W110 | 2 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| SI-BONE INC | COM | 825704109 | 2,916 | 167,000 | SH | SOLE | 167,000 | 0 | 0 | ||
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 15 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
| T2 BIOSYSTEMS INC | COM | 89853L104 | 321 | 2,840,000 | SH | SOLE | 2,840,000 | 0 | 0 | ||
| TC BIOPHARM HOLDINGS PLC | *W EXP 02/08/202 | 87807D111 | 118 | 941,176 | SH | SOLE | 941,176 | 0 | 0 | ||
| TG VENTURE ACQUISITION CORP | UNIT 08/15/2028 | 87251T208 | 2,020 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 1,642 | 1,066,157 | SH | SOLE | 1,066,157 | 0 | 0 | ||
| TURMERIC ACQUISITION CORP | CL A | G9127T108 | 2,540 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
| TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 2 | 84,666 | SH | SOLE | 84,666 | 0 | 0 | ||
| TWIN VEE POWERCATS CO | COM | 90177C101 | 165 | 67,798 | SH | SOLE | 67,798 | 0 | 0 | ||
| TWIST BIOSCIENCE CORP | COM | 90184D100 | 2,396 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 1,970 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| UNITY BIOTECHNOLOGY INC | COM | 91381U101 | 1,687 | 4,270,000 | SH | SOLE | 4,270,000 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 2,550 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| VERICEL CORP | COM | 92346J108 | 1,856 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 4,129 | 404,000 | SH | SOLE | 404,000 | 0 | 0 | ||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 144 | 15,788 | SH | SOLE | 15,788 | 0 | 0 | ||
| WEARABLE DEVICES LTD | *W EXP 09/14/202 | M97838110 | 295 | 1,411,600 | SH | SOLE | 1,411,600 | 0 | 0 | ||
| WESTERN ACQSTN VENTURES CORP | UNIT 09/01/2026 | 95758L206 | 1,010 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| XTANT MED HLDGS INC | COM NEW | 98420P308 | 4,496 | 6,246,291 | SH | SOLE | 6,246,291 | 0 | 0 | ||